Global and China Recombinant Vector Vaccines Market Insights, Forecast to 2027

Global and China Recombinant Vector Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Recombinant Vector Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Vector Vaccines Market Size Growth Rate by Type
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Recombinant Vector Vaccines Market Size Growth Rate by Application
1.3.2 For Adult
1.3.3 For Child
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Vector Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Recombinant Vector Vaccines Revenue 2016-2027
2.1.2 Global Recombinant Vector Vaccines Sales 2016-2027
2.2 Global Recombinant Vector Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Recombinant Vector Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Recombinant Vector Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Recombinant Vector Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Recombinant Vector Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Recombinant Vector Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Recombinant Vector Vaccines Revenue Forecast by Region (2022-2027)
3 Global Recombinant Vector Vaccines Competitor Landscape by Players
3.1 Global Top Recombinant Vector Vaccines Manufacturers by Sales
3.1.1 Global Recombinant Vector Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Recombinant Vector Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Recombinant Vector Vaccines Manufacturers by Revenue
3.2.1 Key Recombinant Vector Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Recombinant Vector Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Recombinant Vector Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Recombinant Vector Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Recombinant Vector Vaccines Revenue in 2020
3.2.6 Global Recombinant Vector Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Recombinant Vector Vaccines Price by Manufacturers
3.4 Global Recombinant Vector Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Vector Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Vector Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Vector Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Recombinant Vector Vaccines Market Size by Type (2016-2021)
4.1.1 Global Recombinant Vector Vaccines Sales by Type (2016-2021)
4.1.2 Global Recombinant Vector Vaccines Revenue by Type (2016-2021)
4.1.3 Recombinant Vector Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Recombinant Vector Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Recombinant Vector Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Vector Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Recombinant Vector Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Recombinant Vector Vaccines Market Size by Application (2016-2021)
5.1.1 Global Recombinant Vector Vaccines Sales by Application (2016-2021)
5.1.2 Global Recombinant Vector Vaccines Revenue by Application (2016-2021)
5.1.3 Recombinant Vector Vaccines Price by Application (2016-2021)
5.2 Recombinant Vector Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Recombinant Vector Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Vector Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Recombinant Vector Vaccines Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Recombinant Vector Vaccines Sales YoY Growth 2016-2027
6.1.2 China Recombinant Vector Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Recombinant Vector Vaccines Market Share in Global Market 2016-2027
6.2 China Recombinant Vector Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Recombinant Vector Vaccines Players by Sales (2016-2021)
6.2.2 China Top Recombinant Vector Vaccines Players by Revenue (2016-2021)
6.3 China Recombinant Vector Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Recombinant Vector Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Recombinant Vector Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Recombinant Vector Vaccines Price by Type (2016-2021)
6.4 China Recombinant Vector Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Recombinant Vector Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Recombinant Vector Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Recombinant Vector Vaccines Price Forecast by Type (2022-2027)
6.5 China Recombinant Vector Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Recombinant Vector Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Recombinant Vector Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Recombinant Vector Vaccines Price by Application (2016-2021)
6.6 China Recombinant Vector Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Recombinant Vector Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Recombinant Vector Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Recombinant Vector Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
7.2 North America Recombinant Vector Vaccines Market Facts & Figures by Country
7.2.1 North America Recombinant Vector Vaccines Sales by Country (2016-2021)
7.2.2 North America Recombinant Vector Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Recombinant Vector Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Recombinant Vector Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Recombinant Vector Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Recombinant Vector Vaccines Market Facts & Figures by Country
9.2.1 Europe Recombinant Vector Vaccines Sales by Country (2016-2021)
9.2.2 Europe Recombinant Vector Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Recombinant Vector Vaccines Market Facts & Figures by Country
10.2.1 Latin America Recombinant Vector Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Recombinant Vector Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Recombinant Vector Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Recombinant Vector Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Recombinant Vector Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Recombinant Vector Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 SANOFI PASTEUR S.A.
12.1.1 SANOFI PASTEUR S.A. Corporation Information
12.1.2 SANOFI PASTEUR S.A. Description and Business Overview
12.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Products Offered
12.1.5 SANOFI PASTEUR S.A. Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Recombinant Vector Vaccines Products Offered
12.2.5 Novartis Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GSK Recombinant Vector Vaccines Products Offered
12.3.5 GSK Recent Development
12.4 CNBG
12.4.1 CNBG Corporation Information
12.4.2 CNBG Description and Business Overview
12.4.3 CNBG Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CNBG Recombinant Vector Vaccines Products Offered
12.4.5 CNBG Recent Development
12.5 ChengDa Bio
12.5.1 ChengDa Bio Corporation Information
12.5.2 ChengDa Bio Description and Business Overview
12.5.3 ChengDa Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ChengDa Bio Recombinant Vector Vaccines Products Offered
12.5.5 ChengDa Bio Recent Development
12.6 Changsheng Life
12.6.1 Changsheng Life Corporation Information
12.6.2 Changsheng Life Description and Business Overview
12.6.3 Changsheng Life Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Changsheng Life Recombinant Vector Vaccines Products Offered
12.6.5 Changsheng Life Recent Development
12.7 Zhifei
12.7.1 Zhifei Corporation Information
12.7.2 Zhifei Description and Business Overview
12.7.3 Zhifei Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zhifei Recombinant Vector Vaccines Products Offered
12.7.5 Zhifei Recent Development
12.8 SINOVAC BIOTECH
12.8.1 SINOVAC BIOTECH Corporation Information
12.8.2 SINOVAC BIOTECH Description and Business Overview
12.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 SINOVAC BIOTECH Recombinant Vector Vaccines Products Offered
12.8.5 SINOVAC BIOTECH Recent Development
12.9 NuoCheng Bio
12.9.1 NuoCheng Bio Corporation Information
12.9.2 NuoCheng Bio Description and Business Overview
12.9.3 NuoCheng Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 NuoCheng Bio Recombinant Vector Vaccines Products Offered
12.9.5 NuoCheng Bio Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Corporation Information
12.10.2 Hualan Bio Description and Business Overview
12.10.3 Hualan Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hualan Bio Recombinant Vector Vaccines Products Offered
12.10.5 Hualan Bio Recent Development
12.11 SANOFI PASTEUR S.A.
12.11.1 SANOFI PASTEUR S.A. Corporation Information
12.11.2 SANOFI PASTEUR S.A. Description and Business Overview
12.11.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Products Offered
12.11.5 SANOFI PASTEUR S.A. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Recombinant Vector Vaccines Industry Trends
13.2 Recombinant Vector Vaccines Market Drivers
13.3 Recombinant Vector Vaccines Market Challenges
13.4 Recombinant Vector Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Vector Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Recombinant Vector Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Varicella
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Polio
Table 5. Major Manufacturers of Hepatitis A
Table 6. Major Manufacturers of Rabies
Table 7. Major Manufacturers of BCG
Table 8. Major Manufacturers of Hepatitis B
Table 9. Major Manufacturers of Pertussis, Diphtheria, tetanus
Table 10. Major Manufacturers of Pneumococcal
Table 11. Major Manufacturers of Others
Table 12. Global Recombinant Vector Vaccines Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 13. Global Recombinant Vector Vaccines Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 14. Global Recombinant Vector Vaccines Sales by Regions (2016-2021) & (K Doses)
Table 15. Global Recombinant Vector Vaccines Sales Market Share by Regions (2016-2021)
Table 16. Global Recombinant Vector Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 17. Global Recombinant Vector Vaccines Sales Forecast by Region (2022-2027) & (K Doses)
Table 18. Global Recombinant Vector Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 19. Global Recombinant Vector Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 20. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 21. Global Recombinant Vector Vaccines Sales by Manufacturers (2016-2021) (K Doses)
Table 22. Global Recombinant Vector Vaccines Sales Share by Manufacturers (2016-2021)
Table 23. Ranking of Global Top Recombinant Vector Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 24. Recombinant Vector Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 25. Recombinant Vector Vaccines Revenue Share by Manufacturers (2016-2021)
Table 26. Global Recombinant Vector Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 27. Global Recombinant Vector Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vector Vaccines as of 2020)
Table 28. Key Manufacturers Recombinant Vector Vaccines Price (2016-2021) (USD/Dose)
Table 29. Recombinant Vector Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Recombinant Vector Vaccines Product Type
Table 31. Date of International Manufacturers Enter into Recombinant Vector Vaccines Market
Table 32. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 33. Global Recombinant Vector Vaccines Sales by Type (2016-2021) (K Doses)
Table 34. Global Recombinant Vector Vaccines Sales Share by Type (2016-2021)
Table 35. Global Recombinant Vector Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 36. Global Recombinant Vector Vaccines Revenue Share by Type (2016-2021)
Table 37. Recombinant Vector Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 38. Global Recombinant Vector Vaccines Sales Forecast by Type (2022-2027) & (K Doses)
Table 39. Global Recombinant Vector Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 40. Global Recombinant Vector Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 41. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 42. Global Recombinant Vector Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 43. Global Recombinant Vector Vaccines Sales by Application (2016-2021) (K Doses)
Table 44. Global Recombinant Vector Vaccines Sales Share by Application (2016-2021)
Table 45. Global Recombinant Vector Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 46. Global Recombinant Vector Vaccines Revenue Share by Application (2016-2021)
Table 47. Recombinant Vector Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 48. Global Recombinant Vector Vaccines Sales Forecast by Application (2022-2027) & (K Doses)
Table 49. Global Recombinant Vector Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 50. Global Recombinant Vector Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 51. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 52. Global Recombinant Vector Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 53. China Recombinant Vector Vaccines Sales (K Doses) of Key Companies (2016-2021)
Table 54. China Recombinant Vector Vaccines Sales Share by Company (2016-2021)
Table 55. China Recombinant Vector Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 56. China Recombinant Vector Vaccines Revenue Share by Company (2016-2021)
Table 57. China Recombinant Vector Vaccines Sales (K Doses) by Type (2016-2021)
Table 58. China Recombinant Vector Vaccines Sales Share by Type (2016-2021)
Table 59. China Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 60. China Recombinant Vector Vaccines Price (USD/Dose) by Type (2016-2021)
Table 61. China Recombinant Vector Vaccines Sales (K Doses) by Type (2022-2027)
Table 62. China Recombinant Vector Vaccines Sales Share by Type (2022-2027)
Table 63. China Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 64. China Recombinant Vector Vaccines Revenue Share by Type (2022-2027)
Table 65. China Recombinant Vector Vaccines Price (USD/Dose) by Type (2022-2027)
Table 66. China Recombinant Vector Vaccines Sales (K Doses) by Application (2016-2021)
Table 67. China Recombinant Vector Vaccines Sales Share by Application (2016-2021)
Table 68. China Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 69. China Recombinant Vector Vaccines Price (USD/Dose) by Application (2016-2021)
Table 70. China Recombinant Vector Vaccines Sales (K Doses) by Application (2022-2027)
Table 71. China Recombinant Vector Vaccines Sales Share by Application (2022-2027)
Table 72. China Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 73. China Recombinant Vector Vaccines Revenue Share by Application (2022-2027)
Table 74. China Recombinant Vector Vaccines Price (USD/Dose) by Application (2022-2027)
Table 75. North America Recombinant Vector Vaccines Sales by Country (2016-2021) & (K Doses)
Table 76. North America Recombinant Vector Vaccines Sales Market Share by Country (2016-2021)
Table 77. North America Recombinant Vector Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. North America Recombinant Vector Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Asia Pacific Recombinant Vector Vaccines Sales by Region (2016-2021) & (K Doses)
Table 80. Asia Pacific Recombinant Vector Vaccines Sales Market Share by Region (2016-2021)
Table 81. Asia Pacific Recombinant Vector Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Recombinant Vector Vaccines Revenue Market Share by Region (2016-2021)
Table 83. Europe Recombinant Vector Vaccines Sales by Country (2016-2021) & (K Doses)
Table 84. Europe Recombinant Vector Vaccines Sales Market Share by Country (2016-2021)
Table 85. Europe Recombinant Vector Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Europe Recombinant Vector Vaccines Revenue Market Share by Country (2016-2021)
Table 87. Latin America Recombinant Vector Vaccines Sales by Country (2016-2021) & (K Doses)
Table 88. Latin America Recombinant Vector Vaccines Sales Market Share by Country (2016-2021)
Table 89. Latin Americaa Recombinant Vector Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 90. Latin America Recombinant Vector Vaccines Revenue Market Share by Country (2016-2021)
Table 91. Middle East and Africa Recombinant Vector Vaccines Sales by Country (2016-2021) & (K Doses)
Table 92. Middle East and Africa Recombinant Vector Vaccines Sales Market Share by Country (2016-2021)
Table 93. Middle East and Africa Recombinant Vector Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 94. Middle East and Africa Recombinant Vector Vaccines Revenue Market Share by Country (2016-2021)
Table 95. SANOFI PASTEUR S.A. Corporation Information
Table 96. SANOFI PASTEUR S.A. Description and Business Overview
Table 97. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 98. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product
Table 99. SANOFI PASTEUR S.A. Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 103. Novartis Product
Table 104. Novartis Recent Development
Table 105. GSK Corporation Information
Table 106. GSK Description and Business Overview
Table 107. GSK Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. GSK Product
Table 109. GSK Recent Development
Table 110. CNBG Corporation Information
Table 111. CNBG Description and Business Overview
Table 112. CNBG Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. CNBG Product
Table 114. CNBG Recent Development
Table 115. ChengDa Bio Corporation Information
Table 116. ChengDa Bio Description and Business Overview
Table 117. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. ChengDa Bio Product
Table 119. ChengDa Bio Recent Development
Table 120. Changsheng Life Corporation Information
Table 121. Changsheng Life Description and Business Overview
Table 122. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Changsheng Life Product
Table 124. Changsheng Life Recent Development
Table 125. Zhifei Corporation Information
Table 126. Zhifei Description and Business Overview
Table 127. Zhifei Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Zhifei Product
Table 129. Zhifei Recent Development
Table 130. SINOVAC BIOTECH Corporation Information
Table 131. SINOVAC BIOTECH Description and Business Overview
Table 132. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. SINOVAC BIOTECH Product
Table 134. SINOVAC BIOTECH Recent Development
Table 135. NuoCheng Bio Corporation Information
Table 136. NuoCheng Bio Description and Business Overview
Table 137. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. NuoCheng Bio Product
Table 139. NuoCheng Bio Recent Development
Table 140. Hualan Bio Corporation Information
Table 141. Hualan Bio Description and Business Overview
Table 142. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Hualan Bio Product
Table 144. Hualan Bio Recent Development
Table 145. Kangtai Corporation Information
Table 146. Kangtai Description and Business Overview
Table 147. Kangtai Recombinant Vector Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. Kangtai Product
Table 149. Kangtai Recent Development
Table 150. Recombinant Vector Vaccines Market Trends
Table 151. Recombinant Vector Vaccines Market Drivers
Table 152. Recombinant Vector Vaccines Market Challenges
Table 153. Recombinant Vector Vaccines Market Restraints
Table 154. Recombinant Vector Vaccines Customers List
Table 155. Recombinant Vector Vaccines Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Vector Vaccines Product Picture
Figure 2. Global Recombinant Vector Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Varicella Product Picture
Figure 4. Influenza Product Picture
Figure 5. Polio Product Picture
Figure 6. Hepatitis A Product Picture
Figure 7. Rabies Product Picture
Figure 8. BCG Product Picture
Figure 9. Hepatitis B Product Picture
Figure 10. Pertussis, Diphtheria, tetanus Product Picture
Figure 11. Pneumococcal Product Picture
Figure 12. Others Product Picture
Figure 13. Global Recombinant Vector Vaccines Sales Market Share by Application in 2020 & 2027
Figure 14. For Adult
Figure 15. For Child
Figure 16. Recombinant Vector Vaccines Report Years Considered
Figure 17. Global Recombinant Vector Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Recombinant Vector Vaccines Market Size 2016-2027 (US$ Million)
Figure 19. Global Recombinant Vector Vaccines Sales 2016-2027 (K Doses)
Figure 20. Global Recombinant Vector Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global Recombinant Vector Vaccines Sales Market Share by Region (2016-2021)
Figure 22. Global Recombinant Vector Vaccines Sales Market Share by Region in 2020
Figure 23. Global Recombinant Vector Vaccines Revenue Market Share by Region (2016-2021)
Figure 24. Global Recombinant Vector Vaccines Revenue Market Share by Region in 2020
Figure 25. Global Recombinant Vector Vaccines Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by Recombinant Vector Vaccines Revenue in 2020
Figure 27. Recombinant Vector Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Recombinant Vector Vaccines Sales Market Share by Type (2016-2021)
Figure 29. Global Recombinant Vector Vaccines Sales Market Share by Type in 2020
Figure 30. Global Recombinant Vector Vaccines Revenue Market Share by Type (2016-2021)
Figure 31. Global Recombinant Vector Vaccines Revenue Market Share by Type in 2020
Figure 32. Global Recombinant Vector Vaccines Sales Market Share by Application (2016-2021)
Figure 33. Global Recombinant Vector Vaccines Sales Market Share by Application in 2020
Figure 34. Global Recombinant Vector Vaccines Revenue Market Share by Application (2016-2021)
Figure 35. Global Recombinant Vector Vaccines Revenue Market Share by Application in 2020
Figure 36. China Recombinant Vector Vaccines Sales Growth Rate 2016-2027 (K Doses)
Figure 37. China Recombinant Vector Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. China Recombinant Vector Vaccines Market Share in Global Market 2016-2027
Figure 39. China 5 and 10 Largest Recombinant Vector Vaccines Players Market Share by Revenue in Recombinant Vector Vaccines in 2020
Figure 40. China Recombinant Vector Vaccines Revenue Share by Type (2016-2021)
Figure 41. China Recombinant Vector Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 42. China Recombinant Vector Vaccines Revenue Share by Application (2016-2021)
Figure 43. China Recombinant Vector Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 44. North America Recombinant Vector Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 45. North America Recombinant Vector Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. North America Recombinant Vector Vaccines Sales Market Share by Country in 2020
Figure 47. North America Recombinant Vector Vaccines Revenue Market Share by Country in 2020
Figure 48. U.S. Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 49. U.S. Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Canada Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 51. Canada Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Europe Recombinant Vector Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 53. Europe Recombinant Vector Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 54. Europe Recombinant Vector Vaccines Sales Market Share by Country in 2020
Figure 55. Europe Recombinant Vector Vaccines Revenue Market Share by Country in 2020
Figure 56. Germany Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 57. Germany Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. France Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 59. France Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. U.K. Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 61. U.K. Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Italy Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 63. Italy Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Russia Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 65. Russia Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Asia Pacific Recombinant Vector Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 67. Asia Pacific Recombinant Vector Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 68. Asia Pacific Recombinant Vector Vaccines Sales Market Share by Region in 2020
Figure 69. Asia Pacific Recombinant Vector Vaccines Revenue Market Share by Region in 2020
Figure 70. China Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 71. China Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Japan Recombinant Vector Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 73. Japan Recombinant Vector Vaccines Revenue Growth Rate (2016-2021) (US$ Million)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs